
CAS 1186048-33-8
:Betamethasone Tripropionate
Description:
Betamethasone tripropionate is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties, primarily used in dermatological and systemic treatments. It is characterized by its high potency and effectiveness in reducing inflammation and suppressing immune responses. The substance is typically formulated as an ester, which enhances its skin penetration and bioavailability. Betamethasone tripropionate is often utilized in various topical preparations, such as creams and ointments, for conditions like eczema, psoriasis, and allergic reactions. Its mechanism of action involves the modulation of gene expression, leading to decreased production of pro-inflammatory cytokines and other mediators. The compound is generally well-tolerated, but potential side effects may include skin irritation, atrophy, or systemic effects with prolonged use. As with all corticosteroids, it is important to use betamethasone tripropionate under medical supervision to minimize risks and ensure appropriate therapeutic outcomes.
Formula:C31H41FO8
Synonyms:- BetaMethasone 11,17,21-Tripropionate
- Betamethasone Dipropionate impurity 5/Betamethasone Dipropionate EP Impurity G/Betamethasone Tripropionate
- Betamethasone Dipropionate Impurity 7(Betamethasone Dipropionate EP Impurity G)
- Betamethasone Dipropionate EP Impurity G(Betamethasone Tripropionate)
- Betamethasone Tripropionate
- Pregna-1,4-diene-3,20-dione, 9-fluoro-16-methyl-11,17,21-tris(1-oxopropoxy)-, (11β,16β)-
- Betamethasone Dipropionate EP Impurity G
- [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-10,13,16-trimethyl-3-oxo-11,17-di(propanoyloxy)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
- (11β,16β)-9-Fluoro-16-Methyl-11,17,21-tris(1-oxopropoxy)pregna-1,4-diene-3,20-dione
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
Betamethasone Tripropionate
CAS:Formula:C31H41FO8Purity:94%Color and Shape:SolidMolecular weight:560.6508(8S,9R,10S,11S,13S,14S,16S,17R)-9-Fluoro-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-11,17-diyl dipropionate (Betamethasone Dipropionate Impurity)
CAS:(8S,9R,10S,11S,13S,14S,16S,17R)-9-Fluoro-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-11,17-diyl dipropionate (Betamethasone Dipropionate Impurity)Purity:98%Betamethasone Dipropionate EP Impurity G (Betamethasone Tripropionate)
CAS:Formula:C31H41FO8Color and Shape:Off-White SolidMolecular weight:560.66Betamethasone Tripropionate
CAS:<p>Impurity Betamethasone Dipropionate EP Impurity G<br>Applications Betamethasone Tripropionate (Betamethasone Dipropionate EP Impurity G) is a Betamethasone (B327000) related compound.<br>References Grootveld, M., et al.: Biochem. Pharmacol., 37, 271 (1988), Chen, B., et al.: Steriods, 74, 30 (2009), Mikami, E., et al.: J. Pharm. Biomed. Anal., 28, 261 (2002),<br></p>Formula:C31H41FO8Color and Shape:NeatMolecular weight:560.65Betamethasone tripropionate
CAS:Controlled Product<p>Betamethasone tripropionate is a pharmaceutical compound that contains the active ingredient betamethasone. It is used as an implantable drug for treatment of inflammatory skin diseases and other conditions such as dermatitis, eczema, psoriasis, and acne. Betamethasone tripropionate is administered by injection or subcutaneous implantation under the skin. The drug is effective in reducing inflammation and relieving itchiness.</p>Formula:C31H41FO8Purity:Min. 95%Molecular weight:560.65 g/mol






